| Market Cap | ₹4,515.69 CrChemicals |
|---|---|
| Sector PE | 37.49Industry Avg |
| Promoter Holding | 75.25%Post-IPO |
| 1Yr Change | 12.87%Stock Return |
| Metric | Q1-27 | Q4-26 | Q1-26 |
|---|---|---|---|
| Revenue from Operations | 434 | 335 | 320 |
| Other Income | 1.7 | 2.3 | 0.9 |
| Total Income | 435 | 337 | 320 |
| Profit Before Tax | 83.6 | 26.6 | 32.8 |
| Net Profit | 61.0 | 19.6 | 24.3 |
| Operating Margin | 19.2% | 7.9% | 10.2% |
| Net Profit QoQ | +211.2% | ||
| Net Profit YoY | +151.0% | ||
| Adj. Profit QoQ | +237.0% | ||
| Adj. Profit YoY | +156.7% | ||
Key highlights
- Net profit surged 151.0% year-on-year to ₹61.0 crore for the quarter ended June 30, 2026
- Revenue from operations grew to ₹434 crore, up from ₹320 crore in the year-ago quarter
- Operating margins expanded to 19.2%, a sharp rise from 10.2% in Q1-26 and 7.9% in Q4-26
- The company successfully listed on NSE and BSE on September 16, 2026, following a ₹500 crore IPO
- Board noted the upcoming retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective September 30, 2026
How the Quarter Went
Prasol Chemicals demonstrated significant financial momentum in the first quarter of fiscal 2027, reporting revenue from operations of ₹434 crore. This represents a 35.6% increase compared to ₹320 crore in the corresponding quarter of the previous year and a sequential growth of 29.5% from ₹335 crore in Q4-26. The bottom-line performance was even more pronounced, with net profit surging 151.0% year-on-year to reach ₹61.0 crore.
Total income for the period stood at ₹435 crore, supported by other income of ₹1.7 crore. This growth trajectory reflects steady volume expansion and pricing resilience in the company's core specialty chemical portfolios.
Margins and Profitability
The company's profitability profile saw a substantial improvement during the quarter under review. Operating margins climbed to 19.2%, marking a sharp rise from the 10.2% reported in Q1-26 and nearly triple the 7.9% recorded in the immediate preceding quarter. Consequently, profit before tax jumped to ₹83.6 crore from ₹32.8 crore a year ago.
These results were achieved even as the company navigated Initial Public Offer (IPO) related expenses totaling ₹31.86 million. These expenditures are currently included under other current assets and are slated to be adjusted against the securities premium account once the IPO process is finalized.
Business Overview
Prasol Chemicals is a leading manufacturer of acetone- and phosphorus-based specialty chemicals, operating through two manufacturing facilities in Maharashtra. The company's product portfolio includes over 150 specialty chemicals that serve diverse end-user industries including pharmaceuticals, agrochemicals, personal care, and performance industries such as lubricant additives and mining. Its business is concentrated in a single primary segment, Speciality Chemicals.
Following its IPO in September 2026, the company raised ₹5,000 million to fund its strategic objectives. The firm maintains an export reach spanning over 60 countries, leveraging its integrated value chain to service global demand for specialized chemical intermediates.
Industry Landscape
The Indian specialty chemicals sector is currently navigating a period of transition characterized by global pricing shifts and raw material volatility. Despite these headwinds, Prasol Chemicals' net profit growth of 151.0% significantly outperformed the broader sector average of 54.32% for the same period. The company maintains a market capitalization of ₹4,515.69 crore and a price-to-book value of 10.06.
With a robust promoter holding of 75.25% following its recent listing, the company is positioned to capitalize on structural domestic demand and increasing global shifts toward resilient supply chain partnerships in the chemical manufacturing space.
Corporate Updates
- The company completed its IPO of 7,396,437 equity shares at an issue price of ₹676, raising a total of ₹5,000 million.
- Prasol Chemicals shares debuted on the National Stock Exchange and BSE Limited on September 16, 2026.
- Dr. Chitra Vaidya, Vice-President – R&D and Senior Management Personnel, will retire from the company on September 30, 2026.
- The retirement follows a two-month service extension granted by management to ensure a smooth leadership transition in the R&D department.
- The Board of Directors approved the unaudited financial results in their meeting concluded at 06:45 P.M. on September 28, 2026.
“The aforesaid financial results of the Company have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013.”
| Share price | ₹763 |
|---|---|
| Market capitalisation | ₹4,515.69 Cr |
| Revenue (annual) | ₹1,232.59 Cr |
| Net profit (annual) | ₹83.12 |
| Promoter holding | 75.25% |
| FII holding | 0.18%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Prasol Chemicals Ltd announcing its unaudited standalone financial results for the quarter ended June 30, 2026. Market figures from a third-party data provider.
Track Prasol Chemicals live
Get the next Prasol Chemicals filing on Telegram seconds after it lands. 15 days free.
